- NCIt
- C5478
Loading cancer entity…
Loading cancer entity…
Clinical trials
110 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03525080 | Comparison of 6-fluoro-[18F]-L-dihydroxyphenylalanine (18F-DOPA) Positron Emission Tomography (PET) and Multiparametric Resonance Magnetic Imagery (RMI) in Initial Exploration of Glial Tumors(GLIROPA) | completed | N/A | 16 | Center Eugene MarquisOTHER | 1 | Jan 27, 2020 | clinicaltrials |
| NCT01342757 | Magnetic Resonance Spectroscopy Imaging in Predicting Response to Vorinostat and Temozolomide in Patients With Recurrent or Progressive Glioblastoma | completed | N/A | 12 | National Cancer Institute (NCI)NIH |
| 1 |
| Jan 29, 2018 |
| clinicaltrials |
| NCT00660543 | MRI Study With Ferumoxytol in Assessing Early Response in Patients With Glioblastoma Multiforme Receiving Temozolomide and Radiation Therapy | completed | N/A | 14 | OHSU Knight Cancer InstituteOTHER | 1 | May 16, 2017 | clinicaltrials |
| NCT01269918 | A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain(RemivsDex) | completed | N/A | 142 | The Cleveland ClinicOTHER | 1 | Dec 20, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jan 27, 2020source: clinicaltrials